lactic acid has been researched along with Chronic Hepatitis B in 7 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "None of the patients developed lactic acidosis during follow-up [median: 58 (6-155) months]." | 3.85 | Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis. ( Aggeletopoulou, I; Anastassiou, ED; Assimakopoulos, S; Gogos, C; Kalafateli, M; Labropoulou-Karatza, C; Mandellou, M; Taprantzi, D; Thomopoulos, K; Triantos, C; Tselekouni, P; Tsiaoussis, G; Vourli, G, 2017) |
| " L-FMAU also has respectable bioavailability in rats." | 2.40 | Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. ( Boudinot, FD; Cheng, YC; Choi, Y; Chu, CK; Cote, PJ; Gerin, JL; Hong, JH; Korba, BE; Peek, SF; Tennant, BC, 1998) |
| "Twenty-nine patients with chronic hepatitis B (CHB), 28 with compensated LC, 33 with decompensated LC, 24 with spontaneous bacterial peritonitis (SBP), 26 with acute-on-chronic liver failure (ACLF), and 24 with decompensated LC complicated by hepatocellular carcinoma (HCC) were recruited." | 1.51 | Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease. ( Biviano, I; Gong, Z; Hu, J; Liu, H; Wang, A; Wang, Z, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, T | 1 |
| Hu, F | 1 |
| Yue, H | 1 |
| Yang, T | 1 |
| Ma, G | 1 |
| Chen, W | 1 |
| You, J | 1 |
| Chen, J | 1 |
| Zhu, Y | 1 |
| Triantos, C | 1 |
| Kalafateli, M | 1 |
| Aggeletopoulou, I | 1 |
| Mandellou, M | 1 |
| Assimakopoulos, S | 1 |
| Tselekouni, P | 1 |
| Taprantzi, D | 1 |
| Tsiaoussis, G | 1 |
| Vourli, G | 1 |
| Anastassiou, ED | 1 |
| Gogos, C | 1 |
| Labropoulou-Karatza, C | 1 |
| Thomopoulos, K | 1 |
| Ayoub, MM | 1 |
| Elantouny, NG | 1 |
| El-Nahas, HM | 1 |
| Ghazy, FES | 1 |
| Wang, Z | 1 |
| Wang, A | 1 |
| Gong, Z | 1 |
| Biviano, I | 1 |
| Liu, H | 1 |
| Hu, J | 1 |
| Yao, YH | 1 |
| Zhao, WF | 1 |
| Gan, JH | 1 |
| Chu, CK | 1 |
| Boudinot, FD | 1 |
| Peek, SF | 1 |
| Hong, JH | 1 |
| Choi, Y | 1 |
| Korba, BE | 1 |
| Gerin, JL | 1 |
| Cote, PJ | 1 |
| Tennant, BC | 1 |
| Cheng, YC | 1 |
1 review available for lactic acid and Chronic Hepatitis B
| Article | Year |
|---|---|
Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Biological Availability; Cell Line; Deoxycytidine | 1998 |
6 other studies available for lactic acid and Chronic Hepatitis B
| Article | Year |
|---|---|
The incorporation of cationic property and immunopotentiator in poly (lactic acid) microparticles promoted the immune response against chronic hepatitis B.
Topics: Adjuvants, Immunologic; Animals; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Ch | 2020 |
Combining the serum lactic acid level and the lactate clearance rate into the CLIF-SOFA score for evaluating the short-term prognosis of HBV-related ACLF patients.
Topics: Acute-On-Chronic Liver Failure; Adult; Female; Hepatitis B, Chronic; Humans; Lactic Acid; Male; Midd | 2020 |
Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.
Topics: Acidosis, Lactic; Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Therap | 2017 |
Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B.
Topics: Adenine; Animals; Antiviral Agents; Drug Delivery Systems; Drug Liberation; Hepatitis B, Chronic; La | 2018 |
Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Analysis of Variance; Biomarkers; Carcinoma, Hepatocell | 2019 |
[Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure: a retrospective analysis of 97 cases].
Topics: Acute-On-Chronic Liver Failure; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lactic Acid; Progno | 2019 |